FDA Approves Vorasidenib, a New Treatment for Low-Grade Gliomas
A new treatment called vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for people with low-grade gliomas (LGG). This type of
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
A new treatment called vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for people with low-grade gliomas (LGG). This type of
The SNO/ASCO Central Nervous System (CNS) Metastases Conference brought together leading experts, researchers, and clinicians from around the world to discuss the latest advancements in
Double your impact toward our $50,000 goal to accelerate high-risk, high-reward research during GBM Awareness Day (7/17).
In recognition of GBM Awareness Day, discover two emerging researchers taking novel approaches to overcome obstacles in treating glioblastoma.
From surviving brain cancer at 21 to leading a social movement, Matthew Zachary has dedicated his career to making the cancer experience suck less for adolescents and young adults (AYA) around the world.
Are you among the 70% of Americans who haven’t made a will yet? There’s good news… it’s a lot easier than you may think.
After surviving brain cancer at a young age, Savannah Mason is highlighting the pressing need for tailored advocacy and support resources for AYA cancer patients.
After being cleared to hike again after GBM surgery, Darrell and Andrea are back on their quest to see every national park in the country and make the most of each day.
We’re in the midst of Brain Tumor Awareness Month (BTAM) and hope you’re as inspired as we are by the outpouring of community support. Not
Always free for patients & caregivers
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631